We will outline some common GLP-1RAs, including liraglutide, exenatide, dulaglutide, and lixisenatide, along with their efficacy and limitations regarding cognitive function as observed in clinical trials (Table 1)
IGF-1 is necessary as well as sufficient in muscle growth (anabolic) and has been shown to also be highly anti-catabolic agent as well
During the study period, 221 patients were screened for eligibility
usually mentioned as mild to moderate and temporary as dose escalation is intended, so in most cases, they are resolved after the maintenance dose is reached (153)
GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro are increasingly prescribed for obesity and type 2 diabetes due to their proven effectiveness in reducing appetite, promoting weight loss, and lowering blood glucose levels.(1, 2) These medications have become extremely popular, fueled by extensive marketing to both healthcare providers and the public